1. METTL3-Mediated N 6 -Methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis. Tsai YC, Hsieh TH, Liao YR, Tsai MT, Lin TP, Lee DY, Park J, Kim D, Susztak K, Yang SF, Lin CC, Li SY. J Am Soc Nephrol. 2024 Oct 1;35(10):1312-1329 (IF 10.3)

2. Circulating Activin A, Kidney Fibrosis, and Adverse Events. Tsai MT, Ou SM, Lee KH, Lin CC, Li SY.  Clin J Am Soc Nephrol. 2024 Feb 1;19(2):169-177. (IF 10.3)

3. DNMT1 in Six2 progenitor cells is essential for transposable element silencing and kidney development. Szu-Yuan Li, Jihwan Park, Kiwung Chung, Rojesh Shrestha, Matthew B Palmer, Katalin Susztak*. J Am Soc Nephrol. 2019 Apr;30(4):594-609.(IF 14.981)

4. Matrix Metalloproteinase-9 Deficiency Attenuates Diabetic Nephropathy by Modulation of Podocyte Functions and Dedifferentiation. Szu-Yuan Li, Po-Hsun Huang, An-Hang Yang, Der-Cherng Tarng, Wu-Chang Yang, Chih-Ching Lin, Jaw-Wen Chen, Geert Schmid-Schönbein, Shing-Jong Lin*. Kidney Int. 2014 Aug;86(2):358-69 (IF 18.998)

5. Four-and-A-Half LIM Protein 2 is a Co-Activator of Wnt Signaling in Diabetic Kidney Disease. Li SY, Huang PH*, Tarng DC, Yang WC, Chang YH, Lin TP, Yang AH, Lin CC, Yang MH, Chen JW, Geert W. Schmid-Schönbein, Chu PH, Lin SJ. J Am Soc Nephrol. 2015 Dec;26(12):3072-84 (IF 14.981)

6. The long noncoding RNA Tug1 connects metabolic changes with kidney disease in podocytes. Li SY, Susztak K. J Clin Invest. 2016 Nov 1;126(11):4072-4075 (IF 19.477)

7. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.Shih CJ, Ou SM, Chao PW, Kuo SC, Lee YJ, Yang CY, Tarng DC, Lin CC, Huang PH, Li SY*, Chen YT*. Circulation. 2016 Jan 19;133(3):265-72 (IF 39.922)